® Regd. Trademark In the management of infectious hepatitis... Liv.52® Unparalleled in liver care ( DROP S , S YRUP, TAB L E T ) • Significantly reduces – Total recovery period – Serum alkaline phosphatase – SGOT and SGPT – Prothrombin time – Serum bilirubin • Significantly increases serum albumin and serum globulin • Restores the metabolic efficiency of the liver • Protects the hepatic parenchyma • Promotes hepatocellular regeneration Liv.52 Unparalleled in liver care LIMAS (Liv.52 Meta-analysis Study) A meta-analysis of 50 clinical studies, conducted over 30 years on 4490 patients, proves the efficacy and safety of Liv.52 in infectious hepatitis. Drops Syrup Tablet Infants 5–10 drops thrice daily – – Children 10–20 drops thrice daily 5 ml thrice daily 1 tablet thrice daily Adults – 10 ml thrice daily 2 tablets thrice daily Dosage Indication Infectious hepatitis L I M A S Evidencebased medicine Liv.52 The only hepatoprotective with a meta-analysis study in infectious hepatitis.
RkJQdWJsaXNoZXIy MjAwNDg=